Emergent Biosolutions (EBS) Misses Q2 EPS by 2c; Mixed Guidance
Tweet Send to a FriendGet Alerts EBS Hot Sheet
Price: $14.59 -2.67%
Revenue Growth %: -14.3%
Financial Fact:
Net income (loss): -8.81M
Today's EPS Names:
ATU, CRWS, CLC, More
Revenue Growth %: -14.3%
Financial Fact:
Net income (loss): -8.81M
Today's EPS Names:
ATU, CRWS, CLC, More
Trade EBS Now!
Emergent Biosolutions (NYSE: EBS) reported Q2 EPS of $0.21, $0.02 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $70.4 million versus the consensus estimate of $76.2 million.
Emergent Biosolutions sees FY2012 revenue of $60-$70 million, versus the consensus of $78.32 million.
Emergent Biosolutions sees FY2012 revenue of $280-$300 million, versus the consensus of $292.99 million.
For earnings history and earnings-related data on Emergent Biosolutions (EBS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Emergent Biosolutions sees FY2012 revenue of $60-$70 million, versus the consensus of $78.32 million.
Emergent Biosolutions sees FY2012 revenue of $280-$300 million, versus the consensus of $292.99 million.
For earnings history and earnings-related data on Emergent Biosolutions (EBS) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Fedex Corp. (FDX) Tops Q4 EPS by 17c, Sales Light
- American Superconductor (AMSC) Reports In-Line Q4 EPS; Guides Q1
- Five Below (FIVE) Tops Q1 EPS by 1c, Boosts FY13 Outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
